ONCOJET PLASMA SOLUTION
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ONCOJET PLASMA SOLUTION Trademark

Serial Number: 79204773 • Registration: 5592329

ONCOJET PLASMA SOLUTION is a trademark filed by Leibniz-Institut für Plasmaforschung und Technologie e.V. on October 21, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Leibniz-Institut für Plasmaforschung und Technologie e.V.

Felix-Hausdorff-Straße 2

Entity Type: 99

Trademark Details

Filing Date

October 21, 2016

Registration Date

October 30, 2018

Published for Opposition

August 14, 2018

Cancellation Date

May 16, 2025

Goods & Services

Medical services; veterinary services; and medical therapeutic services in the field of oncology; healthcare and beauty care for humans and animals; all aforementioned services particularly tailored for the field of oncology

Pharmaceutical and veterinary and therapeutic preparations and substances, namely, pharmaceutical preparations for the treatment of cancer and cancer-related conditions, and veterinary preparations for the treatment of cancer and cancer-related conditions in mammals; sanitary preparations for medical purpose; plasters for medical purposes; medical dressings; teeth filing material and dental impression materials; disinfectants; all aforementioned products particularly for use in oncology

Instruments and devices for plasma medical, veterinary and therapeutic purposes, namely, atmospheric pressure plasma jets and dielectric barrier discharges in the nature of electric therapy apparatus for direct treatment in the nature of treating tumors and tumor cells, and medical plasma devices in the nature of ultrasonic therapy apparatus and liquid dispensers for medical use for generating and applying one or more liquid-based active agents for use in medical tumor therapy; pumps for medical, veterinary and therapeutics use, namely, dispenser pumps for medical purposes for mixing gaseous or liquid agents and for generating low pressure regimes for easier plasma ignition; devices and apparatus for administering or applying medicines and substances for medical, veterinary and therapeutic use, namely, needle-based and needle-free injection systems consisting primarily of needle-free syringes and jet injectors for applying one or more liquid-based active agents, plasma generated reactive gases or direct atmospheric pressure plasma; devices and apparatus for plasma medical use, namely, plasma sources being plasma jets or dielectric barrier discharges for use in the treatment of cancer; and replacement parts and fittings for the aforementioned products; all aforementioned products particularly for use in oncology

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 16, 2026 INTR
CANCELLED SECTION 71
May 16, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 30, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2019 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 6, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 5, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 30, 2018 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 28, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 12, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 12, 2018 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 14, 2018 NPUB
PUBLISHED FOR OPPOSITION
Aug 14, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Aug 10, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 25, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 25, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 25, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 28, 2018 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jun 5, 2018 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Jun 5, 2018 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Jun 5, 2018 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 9, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 11, 2017 GNFN
FINAL REFUSAL E-MAILED
Nov 11, 2017 GNFR
FINAL REFUSAL WRITTEN
Nov 11, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2017 TROA
ATTORNEY REVIEW COMPLETED
Aug 25, 2017 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Aug 25, 2017 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Aug 17, 2017 LIMG
REFUSAL PROCESSED BY IB
May 5, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 20, 2017 RFCS
REFUSAL PROCESSED BY MPU
Apr 20, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 18, 2017 RFCR
NON-FINAL ACTION WRITTEN
Apr 17, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 15, 2017 MAFR
ASSIGNED TO EXAMINER
Apr 11, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 11, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 6, 2017 REPR